Arisue N, Chagaluka G, Palacpac NMQ, et al. Assessment of Mixed Plasmodium falciparum sera5 Infection in Endemic Burkitt Lymphoma: A Case-Control Study in Malawi Cancers (Basel). 2021 Apr 2;13(7):1692.
Peprah S, Ogwang MD, Kerchan P, et al. Inverse association of falciparum positivity with endemic Burkitt lymphoma is robust in analyses adjusting for pre-enrollment malaria in the EMBLEM case-control study Infect Agent Cancer. 2021 Jun 7;16(1):40.
Gouveia MH, Borda V, Leal TP, et al. Origins, admixture dynamics and homogenization of the African gene pool in the Americas. Mol Biol Evol. 2020 Mar 3. [Epub ahead of print]
Kirimunda S, Verboom M, Otim I, et al. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. Br J Haematol 2020 Feb 18.
Mateus H Gouveia, Isaac Otim, Martin D Ogwang, et al. Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility.Leukemia 2020 Oct 13;146(4):953-969. [Epub ahead of print]
Peprah S, Ogwang MD, Kerchan P, et al. Mean platelet counts are relatively decreased with malaria but relatively increased with Endemic Burkitt lymphoma in Uganda, Tanzania, and Kenya. Br J Haematol 2020 May 12. [Epub ahead of print]
Peprah S, Ogwang MD, Kerchan P, et al. Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya. Int J Cancer 2020 Feb 15;146(4):953-969.
Redmond LS, Ogwang MD, Kerchan P, et al. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya. Malar J. 2020;19(1):239.
Derkach A, Otim I, Pfeiffer RM, et al. Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies. EBioMedicine 2019 Jan;39:358-368.
Grande BM, Gerhard DS, Jiang A, et al. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 2019 Mar 21;133(12):1313-1324.
Gouveia MH, Bergen AW, Borda V, et al. Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt". PLoS Genet 2019 Mar 8;15(3):e1008027. eCollection 2019 Mar.
Peprah S, Dhudha H, Ally H, et al. A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania. Trop Med Int Health 2019 Mar 7. [Epub ahead of print]
Peprah S, Tenge C, Genga IO, et al. A Cross-Sectional Population Study of Geographic, Age-Specific, and Household Risk Factors for Asymptomatic Plasmodium falciparum Malaria Infection in Western Kenya. Am J Trop Med Hyg 2019 Jan;100(1):54-65. doi: 10.4269/ajtmh.18-0481.
Liao HM, Liu H, Lei H, et al. Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda. Cancers (Basel). 2018 Jun 2;10(6). pii: E177. doi: 10.3390/cancers10060177.
Maziarz M, Nabalende H, Otim I, et al. A cross-sectional study of asymptomatic Plasmodium falciparum infection burden and risk factors in general population children in 12 villages in northern Uganda. Malar J 2018 Jun 20;17(1):240. doi: 10.1186/s12936-018-2379-1.
Mbulaiteye SM, Anderson WF. Age-related heterogeneity of Burkitt lymphoma. Br J Haematol 2018 Jan;180(1):153-155.
Ravell J, Otim I, Nabalende H, et al. Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda. Cancer Epidemiol 2018 Feb;52:70-74. Erratum in: Cancer Epidemiol. 2018 Aug;55:192.
Agerbaek MØ, Pereira MA, Clausen TM, et al. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration. Int J Cancer 2017 Apr 1;140(7):1597-1608.
Legason ID, Pfeiffer RM, Udquim KI, et al. Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization Study. EBioMedicine 2017 Nov;25:58-65.
Lombardo KA, Coffey DG, Morales AJ, et al. High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis. Blood Adv 2017 Mar 21;1(9):535-544. eCollection 2017 Mar 28.
Maziarz M, Kinyera T, Otim I, et al. Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda. Malar J 2017 Mar 20;16(1):124. doi: 10.1186/s12936-017-1778-z.
Linet MS, Brown LM, Mbulaiteye SM, et al. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer 2016 Apr 15;138(8):1862-74.
Lei H, Li T, Li B, et al. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations. Sci Rep 2015 Nov 23;5:16706. doi: 10.1038/srep16706.3
Adewole I, Martin DN, Williams MJ, et al. Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol 2014 May;11(5):251-9. Review.
Aka P, Emmanuel B, Vila MC, et al. Elevated serum levels of interleukin-6 in endemic Burkitt lymphoma in Ghana. Hematol Oncol 2014 Dec;32(4):218-20.
Johnston WT, Mutalima N, Sun D, et al. Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi. Sci Rep 2014 Jan 17;4:3741. doi: 10.1038/srep03741.
Mbulaiteye SM, Morton LM, Sampson JN, et al. Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014 Aug;2014(48):106-14. doi: 10.1093/jncimonographs/lgu003.
Mbulaiteye SM, Pullarkat ST, Nathwani BN, et al. Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009. APMIS 2014 Jan;122(1):5-15.
Simbiri KO, Biddle J, Kinyera T, et al. Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013. Infect Agent Cancer 2014 Sep 11;9:32. eCollection 2014.
Williams CK, Cristina Stefan D, Rawlinson F, et al. The African Organisation for Research and Training in Cancer and its conferences: a historical perspective and highlights of the Ninth International Conference, Durban, South Africa, 21-24 November 2013. Ecancermedicalscience 2014 Feb 3;8:396. eCollection 2014.
Aka P, Vila MC, Jariwala A, et al. Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response. Blood 2013 Aug 1;122(5):629-35.
Mbulaiteye SM, Clarke CA, Morton LM, et al. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol 2013 Apr;88(4):245-50.
Aka P, Kawira E, Masalu N, et al. Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer 2012 Dec 15;59(7):1234-8.
Baik S, Mbaziira M, Williams M, et al. A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer 2012 Mar 13;7(1):5. doi: 10.1186/1750-9378-7-5.
Guech-Ongey M, Yagi M, Palacpac NM, et al. Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana. Int J Cancer 2012 Apr 15;130(8):1908-14.
Mbulaiteye SM, Anderson WF, Ferlay J, et al. Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol 2012 Jun;87(6):573-8.
Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012 Oct 4;490(7418):116-20.
Emmanuel B, Kawira E, Ogwang MD, et al. African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 2011 Mar;84(3):397-401. doi: 10.4269/ajtmh.2011.10-0450.
Ogwang MD, Zhao W, Ayers LW, Mbulaiteye SM. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch Pathol Lab Med 2011 Apr;135(4):445-50. doi: 10.1043/2009-0443-EP.1.
Mbulaiteye SM, Anderson WF, Bhatia K, et al. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer 2010 Apr 1;126(7):1732-9. doi: 10.1002/ijc.24934.
Mbulaiteye SM, Talisuna AO, Ogwang MD, et al. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet 2010 May 8;375(9726):1661-3.
Mbulaiteye SM, Biggar RJ, Bhatia K, et al. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009 Sep;53(3):366-70. doi: 10.1002/pbc.22047.
Ogwang MD, Bhatia K, Biggar RJ, et al. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008 Dec 1;123(11):2658-63. [View Abstract]